PT  - JOURNAL ARTICLE
AU  - Tembo, Lindiwe
AU  - Sialubanje, Cephas
AU  - Malasa, Martha
AU  - Heilmann, Elizabeth Susan
AU  - Sinyange, Nyambe
AU  - Nawa, Mukumbuta
TI  - Factors Associated with Malaria Infection in Under Five Children-Zambia, 2018. A Secondary Analysis of the Malaria Indicator Survey, 2018
AID  - 10.1101/2023.09.05.23295063
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.09.05.23295063
4099  - http://medrxiv.org/content/early/2023/09/06/2023.09.05.23295063.short
4100  - http://medrxiv.org/content/early/2023/09/06/2023.09.05.23295063.full
AB  - Introduction Malaria is a public health concern in Zambia. In 2018, Zambia reported a 9% malaria prevalence in under-five children, with some provinces reporting above 20%. Factors still driving malaria infection among the country’s under-five children must be investigated. Factors associated with malaria infection among under-five children were investigated.Methods This was a secondary analysis of the cross-sectional study for the Zambia Malaria Indicator Survey 2018 (MIS). Multistage sampling was used in the malaria indicator survey. All children aged 6 to 59 months who received malaria rapid diagnostic tests (RDT) in the data set were considered for the study. Malaria infection: Tested positive or negative for malaria RDT. Sample weights and multivariable logistic regression were used. Backward stepwise regression was used to determine the best model, and the Akaike information criterion was used to select the best model that best fits the data. The Odds ratio measured the association at a 95% confidence level.Results A total of 2400 children were analysed. 24.3% (583) tested positive. The median age was 32 (interquartile range (IQR:8-46)) months. Males were 52% (1,249). The odds of malaria infection increased as the child’s age in months increased (aOR=1.004, 95% CI: 1.003, 1.005). Children in the rural had higher odds of malaria than urban children (aOR=1.11,95% CI: 1.05, 1.17). The odds of malaria in children in Copperbelt, Luapula, Muchinga and North-Western Provinces were higher than in children in Central Province (p-value <0.05). Children whose houses did not receive IRS had increased odds of malaria compared to children whose houses received IRS (aOR=1.05, 95%CI: 1.01, 1.09). Sex was not statistically significant.Conclusion An increase in age, living in the rural and northern parts of Zambia was associated with malaria infection. Increasing malaria prevention and control measures for older children, rural communities, and the northern parts of Zambia may help reduce malaria prevalence.Strengths and LimitationsThe study used a large dataset of the Malaria Indicator Survey 2018 that was powered to be nationally representative of Zambia, urban and rural strata, and provincial levels.The study used a complex data analysis considering household weights, census enumeration areas and provinces, addressing intra-cluster correlations.The study addressed confounding using multivariable regressing and determined the best-fit model using Akaike Information Criteria (AIC) in a backward stepwise regressing.The study’s main limitation is that it is a survey that simultaneously assessed the outcome and exposure variables, eliciting associations only and not causality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ERES Converge Institutional Review Board approved this study in Lusaka, Zambia. The National Health Research Authority further approved it.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors